DDC Enterprise vs Medifast
DDC and MED side by side, both in food and kindred products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DDC and MED compare
DDC Enterprise grew revenue faster over the last twelve months (0.26% versus −30.3% for Medifast).
Medifast scores higher on the StockData Score (10 against 4 for DDC Enterprise), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DDC | MED |
|---|---|---|
| Size and price | ||
| Market cap | – | $145M |
| Share price | $0.130 | $12.97 |
| Change, 1 year | −97.7% | 11.5% |
| Change, 5 years | – | −94.1% |
| Beta (5Y) | 2.70 | 0.71 |
| Employees | 42 | 380 |
| StockData Score | ||
| Total score | 4 | 10 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 0 | 0 |
| Health score | 2 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 0.5× |
| P/B | – | 0.8× |
| FCF yield | – | −2.7% |
| Fair value | – | $35.80 |
| Margin of safety | – | 63.8% |
| Growth | ||
| Revenue growth (TTM) | 0.26% (better) | −30.3% |
| Revenue growth, 5Y average | – | −16.2% |
| Net income growth (TTM) | – | −16573% |
| EPS growth (TTM) | – | −37000% |
| Profitability | ||
| Gross margin | 31.4% | 69.2% (better) |
| Operating margin | −90.0% | −11.6% (better) |
| Net margin | – | −13.6% |
| FCF margin | −101% | −1.3% (better) |
| Return on equity | – | −20.7% |
| Return on invested capital | −37.5% (better) | −110% |
| Financial health | ||
| Debt / equity | 0.03 (better) | 0.00 |
| Interest coverage | −12.1× | – |
| Current ratio | 1.83 | 4.82 (better) |
| Altman Z-score | – | 3.83 |
| Piotroski F-score | – | 4 |
| Dividends and buybacks | ||
| Dividend yield | – | 0.00% |
| Years of dividend growth | – | 0 |
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | – | 73.9% |
| Held by insiders | 33.5% | 12.3% |
| Insider net buying, 12 months | – | $1.5M |
| Short interest, % of float | – | 13.2% |
Go deeper
- DDC stock overview
- DDC income statement
- DDC valuation and score
- MED stock overview
- MED income statement
- MED valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.